Global Oral Cancer Treatment Market to grow with a CAGR of 5.20 %
Increasing healthcare infrastructure and a
supportive regulatory environment are the major drivers for the Global Oral
Cancer Treatment Market.
According to TechSci Research report, “Global
Oral Cancer Treatment Market Industry Size, Share, Trends, Competition,
Opportunity and Forecast, 2018-2028”, Global
Oral Cancer Treatment Market has valued at USD 2.01 billion in 2022 and is
anticipated to witness an impressive growth in the forecast period with a CAGR
of 5.20% through 2028. This can be due
to collaborations and partnerships among leading companies with a diverse
approach to merge the expertise of individual companies and to strengthen their
position in the market.
Innovations in imaging and diagnostic
technologies have played a significant role in driving the demand for oral
cancer treatment. Advanced imaging technologies, such as cone beam computed
tomography (CBCT) and optical coherence tomography (OCT), allow for the early
detection of oral cancer and precancerous lesions. Early diagnosis is essential
for effective treatment and improved outcomes, which in turn increases the
demand for treatment. High-resolution imaging technologies provide more
accurate and detailed information about the location and extent of tumors. This
precision is crucial in surgical planning and the determination of treatment
modalities, leading to better outcomes. Advanced imaging allows for a better
understanding of the unique characteristics of each patient's cancer. This
information can guide the development of personalized treatment plans,
enhancing the demand for tailored therapies. Three-dimensional imaging and
diagnostic tools help in the planning of radiation therapy and surgery. They
enable healthcare professionals to precisely target the tumor while sparing
healthy tissue, reducing side effects and the need for extensive treatment. Real-time
imaging during surgery can aid surgeons in ensuring complete tumor removal
while minimizing damage to surrounding structures. This is particularly
important in complex oral cancer surgeries.
Browse over XX market data Figures and spread
through XX
Pages and an in-depth TOC on " Global Oral Cancer Treatment Market”
In
September 2023, Viome Life Sciences, a prominent company dedicated to
preventive health technology, has introduced Oral Health Pro with Cancer Detect,
a revolutionary test that is poised to transform the dental industry's approach
to oral care. This innovative test offers dental professionals an unprecedented
level of actionable insights into their patients' health. By leveraging Viome's
proprietary RNA sequencing technology and artificial intelligence (AI), Oral
Health Pro with Cancer Detect measures the gene expression of both the oral
microbiome and human cells in a patient's saliva. This enables the early
detection of biomarkers associated with oral and throat cancer, leading to potentially
life-saving interventions. The significance of this test is underscored by the
FDA's designation of the underlying Cancer Detect technology as a Breakthrough
Device, ensuring an accelerated review process. Oral Health Pro is not only
reshaping how dental professionals and individuals view oral health but also
emphasizing the profound connection between oral well-being and overall bodily
health. The test can identify a wide range of biomarkers related to conditions
such as gum health, cavities, halitosis, pathobiont activity, fungal activity,
and genotoxic activity, many of which have implications for systemic health.
Treatment costs are a significant
challenge in the global oral cancer treatment market. The financial burden
associated with oral cancer treatment can be substantial, and it affects
various stakeholders, including patients, healthcare systems, and governments. Oral
cancer treatment often involves multiple modalities, including surgery,
radiation therapy, chemotherapy, targeted therapy, and immunotherapy. These
treatments can be costly, particularly when they are administered in
combination or over extended periods. Following oral cancer treatment, patients
may require dental rehabilitation to restore oral function and aesthetics. This
may involve procedures such as dental implants, dentures, and other dental
prostheses, which can add to the overall cost. Chemotherapy drugs, targeted
therapies, and immunotherapies can be expensive. Some of these drugs need to be
administered over an extended period, contributing to the financial burden. Advanced
imaging and diagnostic tests play a crucial role in the diagnosis and
monitoring of oral cancer. These tests, such as PET-CT scans and MRI, can be
expensive. Long-term follow-up care and surveillance are necessary to monitor
disease recurrence and manage late-onset side effects. These ongoing medical
expenses can add to the overall treatment costs.
Global Oral
Cancer Treatment Market is segmented based on Type, Treatment, Distribution
Channel, and by region.
Based on the Type,
Global Oral Cancer Treatment Market is segmented Squamous Cell Carcinoma,
Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others. Minor
salivary gland carcinomas are a group of malignant tumors that originate in the
minor salivary glands, which are located throughout the oral cavity and other
parts of the head and neck. These glands are distinct from the major salivary
glands (such as the parotid, submandibular, and sublingual glands) and are
responsible for producing saliva to keep the mouth moist and aid in digestion.
Minor salivary gland carcinomas are relatively rare compared to other types of
oral cancer. However, they are diverse in terms of their location and
histological subtypes, meaning they can occur in various areas of the head and
neck, each with distinct characteristics. There are several histological subtypes of minor salivary gland
carcinomas, each with its unique characteristics. Common subtypes include
mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinoma,
polymorphous low-grade adenocarcinoma, and acinic cell carcinoma.
Based on Region,
North America held the largest share in the Global Oral
Cancer Treatment Market. North America has been a significant location
for clinical trials related to cancer treatment, including oral cancer. This
participation in research helps advance the understanding of disease and the
development of new treatment options. Patients in North America generally have greater
awareness of the importance of cancer screening, including oral cancer. This
awareness leads to higher rates of early detection and diagnosis. The
relatively high economic status of many individuals in North America allows
them to seek and afford advanced treatments and therapies, contributing to the
growth of the oral cancer treatment market. The region has a robust network of
dental and medical professionals who collaborate to provide comprehensive care,
including oral cancer treatment.
Some of the major companies operating in
the Global Oral Cancer Treatment
Market include:
- Novartis AG
- Hospira, Inc.
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc.
- Lilly USA, LLC
- Merck & Co., Inc.
- Fresenius Kabi AG
- Accord BioPharma, Inc.
- Bristol-Myers Squibb Company
- Spectrum Pharmaceuticals, Inc.
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“Certain areas, particularly in North
America, are projected to exert significant demand for Oral Cancer Treatment.
The growth in the competitive landscape and the presence of well-established
companies in the market, committed to enhance the overall wellbeing of people each
year, are expected to contribute to a remarkable growth of the Global Oral
Cancer Treatment Market in the forecast period," said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based Global management
consulting firm.
"Global Oral Cancer Treatment Market by Type (Squamous Cell Carcinoma,
Verrucous Carcinoma, Minor Salivary Gland Carcinomas, Lymphomas, others), by Treatment
(Targeted Therapy, Chemotherapy, Immunotherapy), by Distribution Channel (Hospitals
Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, By Competition Forecast & Opportunities, 2018-2028F" has evaluated the future growth
potential of Global Oral Cancer Treatment Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide innovative market intelligence and help decision makers take
sound investment decisions. Besides, the report also identifies and analyzes
the emerging trends along with essential drivers, challenges, and opportunities
in Global Oral Cancer Treatment Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com